Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the Liver

Table 2

Treatment regimen in the 12 patients treated with hepatic artery embolization.

Patient number	Location of primary disease	Treatment for primary disease	ChemoRx	HAE, line of therapy	Other interventions
1	H&N (paraspinal)	Surgery	None	1^st	Hepatic resection (post-HAE)
2	H&N (brain)	Surgery + radiation	Sunitinib; TMZ + Bev	3^rd	—
3	H&N (brain)	Surgery + radiation	Sorafenib	3^rd	Hepatic resection (pre-HAE)
4	H&N (meningeal)	Surgery + radiation	None	2^nd	Hepatic resection (pre-HAE) + ablation
5	H&N (meningeal)	Surgery + radiation	Sunitinib; Brivanib; TMZ + Bev	4^th	—
6	H&N (meningeal)	Surgery + radiation	Sunitinib; Doxorubicin; TMZ + Bev	1^st	Ablation
7	H&N (meningeal)	Surgery	Doxorubicin; Pazopanib; TMZ + Bev	1^st	Ablation + Y-90
8	Pelvis (presacral)	Radiation + HAE + ChemoRx	Sunitinib	2^nd	Ablation × 2, Y-90
9	Pelvis (presacral)	Surgery + radiation	Ifosfamide; Adriamycin; Dacarbazine; Sunitinib	4^th	Y-90
10	Pleura	Surgery	Pazopanib	2^nd	PVE + ablation
11	Pleura	Surgery	Sunitinib; Pazopanib; TMZ + Bez	4^th	—
12	Thigh	Surgery	Sunitinib	2^nd	—

H&N = head and neck; HAE = hepatic artery embolization; ChemoRx = chemotherapy; surgery = surgical resection; Y-90 = radioembolization; TMZ + Bev = temozolomide + bevacizumab; PVE = portal vein embolization.